miR-200c enhances radiosensitivity of human breast cancer cells

J Cell Biochem. 2013 Mar;114(3):606-15. doi: 10.1002/jcb.24398.

Abstract

Due to the intrinsic resistance of many tumors to radiotherapy, current methods to improve the survival of cancer patients largely depend on increasing tumor radiosensitivity. It is well-known that miR-200c inhibits epithelial-mesenchymal transition (EMT), and enhances cancer cell chemosensitivity. We sought to clarify the effects of miR-200c on the radiosensitization of human breast cancer cells. In this study, we found that low levels of miR-200c expression correlated with radiotolerance in breast cancer cells. miR-200c overexpression could increase radiosensitivity in breast cancer cells by inhibiting cell proliferation, and by increasing apoptosis and DNA double-strand breaks. Additionally, we found that miR-200c directly targeted TANK-binding kinase 1 (TBK1). However, overexpression of TBK1 partially rescued miR-200c mediated apoptosis induced by ionizing radiation. In summary, miR-200c can be a potential target for enhancing the effect of radiation treatment on breast cancer cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / genetics
  • Breast Neoplasms / genetics
  • Breast Neoplasms / radiotherapy*
  • Cell Line, Tumor
  • Cell Proliferation
  • Cell Survival
  • DNA Breaks, Double-Stranded
  • Epithelial-Mesenchymal Transition / genetics
  • Female
  • Humans
  • MCF-7 Cells
  • MicroRNAs / biosynthesis
  • MicroRNAs / genetics*
  • MicroRNAs / metabolism*
  • Protein Serine-Threonine Kinases / biosynthesis
  • Protein Serine-Threonine Kinases / genetics
  • Protein Serine-Threonine Kinases / metabolism*
  • Radiation Tolerance / genetics*
  • Radiation-Sensitizing Agents

Substances

  • MIRN200 microRNA, human
  • MicroRNAs
  • Radiation-Sensitizing Agents
  • Protein Serine-Threonine Kinases
  • TBK1 protein, human